A new study has revealed why some people with Huntington's disease develop symptoms 10–12 years earlier and experience a more aggressive form of the disease.

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. People affected by Huntington’s disease could at last benefit from the ...

A simple change in when people eat may offer a promising new approach for Huntington's disease, according to research led by Oregon Health & Science University. In a 12-week pilot study, researchers ...

Credit: Stock Time-restricted eating proved feasible for people with early Huntington’s disease and produced several unexpected biological signals. A small pilot study suggests that limiting daily ...

Huntington's disease is a hereditary neurodegenerative disorder caused by an autosomal dominant mutation. The hallmark symptom of Huntington's disease is the presence of progressive chorea (abnormal ...

Huntington's disease (HD) has long been impossible to cure, but new research is finally giving fresh hope. HD is a progressive, hereditary brain disease that affects movement, cognition and emotions.

In a small trial, a gene therapy injected into the brain slowed the disease by 75 percent over three years. Huntington’s disease is extremely cruel. Symptoms start with random, uncontrollable twitches ...

In addition to attending Team Hope walks, people can support HD research by attending educational seminars, holding and attending fundraisers, and making donations. People can consider volunteering at ...

A simple change in when people eat—not what they eat—may hold unexpected promise for one of the most devastating neurodegenerative diseases known to medicine. In the first clinical trial of its kin ...

Original article here 💁‍♂️ Also worth reading 💁‍♂️ "My body moves on its own against my will""It's become harder to walk than before""My body feels stiff""I don't feel calm"Huntington's disease is a ...

Treatments that target a fragment of the mutant protein that causes Huntington's disease might be more effective than treatments—now in clinical trials—that target the whole protein but leave this ...

UniQure says it still sees a path to regulatory approval for the drug candidate, AMT-130, even as the experimental gene ...